Atlas Venture Opportunity Fund I, L.P., 10% Owner at Xilio Therapeutics, Inc. (XLO), bought 735,942 shares at $16.00 ($3.0M) on 2021-10-26, disclosed to the SEC on 2021-10-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 548,442 | $0 | 0.0% |
| 2 | $16.00 | 187,500 | $3.0M | 100.0% |
| Total | $4.08 avg | 735,942 | $3.0M | 100% |
| Filing → |